Camboni G - Search Results

1

Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction.

Annibale B, Delle Fave G, Azzoni C, Corleto V, Camboni G, D'Ambra G, Pilato FP, Bordi C. Annibale B, et al. Among authors: camboni g. Aliment Pharmacol Ther. 1994 Feb;8(1):95-104. doi: 10.1111/j.1365-2036.1994.tb00165.x. Aliment Pharmacol Ther. 1994. PMID: 7910489 Clinical Trial.

2

Intragastric and intraoesophageal pH monitoring in duodenal ulcerpatients: effect of the new histamine H2-receptor antagonist ramixotidine.

Molgora M, Basilisco G, Bozzani A, Camboni G, Bianchi PA. Molgora M, et al. Among authors: camboni g. Eur J Clin Pharmacol. 1989;37(4):405-7. doi: 10.1007/BF00558510. Eur J Clin Pharmacol. 1989. PMID: 2574675 Clinical Trial.

3

The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts.

Bello E, Taraboletti G, Colella G, Zucchetti M, Forestieri D, Licandro SA, Berndt A, Richter P, D'Incalci M, Cavalletti E, Giavazzi R, Camboni G, Damia G. Bello E, et al. Among authors: camboni g. Mol Cancer Ther. 2013 Feb;12(2):131-40. doi: 10.1158/1535-7163.MCT-12-0275-T. Epub 2012 Dec 27. Mol Cancer Ther. 2013. PMID: 23270924

4

Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A).

Colle M, Ruedas E, Cazenave J, Auzerie J, Basilisco G, Camboni G, Manara L. Colle M, et al. Among authors: camboni g. Eur J Clin Pharmacol. 1988;35(5):529-34. doi: 10.1007/BF00558249. Eur J Clin Pharmacol. 1988. PMID: 2906873 Clinical Trial.

5

Orocecal transit delay in obese patients.

Basilisco G, Camboni G, Bozzani A, Vita P, Doldi S, Bianchi PA. Basilisco G, et al. Among authors: camboni g. Dig Dis Sci. 1989 Apr;34(4):509-12. doi: 10.1007/BF01536325. Dig Dis Sci. 1989. PMID: 2702881 Clinical Trial.

6

Repeatability of lactulose hydrogen breath test in subjects with normal or prolonged orocecal transit.

Camboni G, Basilisco G, Bozzani A, Bianchi PA. Camboni G, et al. Dig Dis Sci. 1988 Dec;33(12):1525-7. doi: 10.1007/BF01535941. Dig Dis Sci. 1988. PMID: 3197582

7

Oral naloxone antagonizes loperamide-induced delay of orocecal transit.

Basilisco G, Camboni G, Bozzani A, Paravicini M, Bianchi PA. Basilisco G, et al. Among authors: camboni g. Dig Dis Sci. 1987 Aug;32(8):829-32. doi: 10.1007/BF01296704. Dig Dis Sci. 1987. PMID: 3608730 Clinical Trial.

8

Loperamide and oro-caecal transit delay.

Basilisco G, Camboni G, Bozzani A, Bianchi PA. Basilisco G, et al. Among authors: camboni g. Br J Clin Pharmacol. 1986 Sep;22(3):371-2. doi: 10.1111/j.1365-2125.1986.tb02904.x. Br J Clin Pharmacol. 1986. PMID: 3768253 Free PMC article. No abstract available.

9

Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test.

Basilisco G, Bozzani A, Camboni G, Recchia M, Quatrini M, Conte D, Penagini R, Bianchi PA. Basilisco G, et al. Among authors: camboni g. Gut. 1985 Jul;26(7):700-3. doi: 10.1136/gut.26.7.700. Gut. 1985. PMID: 4018633 Free PMC article.

10

Lactose malabsorption and intolerance in Italians. Clinical implications.

Bozzani A, Penagini R, Velio P, Camboni G, Corbellini A, Quatrini M, Conte D, Bianchi PA. Bozzani A, et al. Among authors: camboni g. Dig Dis Sci. 1986 Dec;31(12):1313-6. doi: 10.1007/BF01299809. Dig Dis Sci. 1986. PMID: 3803134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters